Pfizer, Moderna COVID-19 vaccines highly effective after first shot in real-world use, U.S. study shows
March 29, 20212 min read490 words
Published: March 29, 2021  |  2 min read490 words
By , (Reuters) - COVID-19 vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc reduced risk of infection by 80% two weeks or more after the first of two shots, according to data from a real-world U.S. study released on Monday.The risk of infection fell 90% by two wee...
Pfizer, Moderna COVID-19 vaccines highly effective after first shot in real-world use, U.S. study shows Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews
img-trusted
100%
critic score
14 reviews
img-trusted
80%
public score
74 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.